90 related articles for article (PubMed ID: 24579473)
1. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma].
Sun XF; Gu YQ; Wang AC; Wang J; Xie JL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473
[TBL] [Abstract][Full Text] [Related]
2. [Application of liquid-based cytology and high-risk human papillomavirus DNA detection in cervical lesion screening].
Wu D; Ding L; Wu JH; Li ZN
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1421-3. PubMed ID: 17884792
[TBL] [Abstract][Full Text] [Related]
3. [The study of combining high-risk human papillomavirus types checking and cytologic test in the screening of cervical lesions].
Xu XH; Xie ZX; Ma R; Zhang WQ; Li QF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):298-300. PubMed ID: 22097613
[TBL] [Abstract][Full Text] [Related]
4. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
5. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
Zhao J; Zhou JN; Yang YJ; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
[TBL] [Abstract][Full Text] [Related]
6. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
7. [An optoelectronic cervical cancer screening system for screening cervical cancer: comparison with cervical cytology].
He XK; Luo XP; Mao LZ; Chen GY; Li Y; Zhang JY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2304-6. PubMed ID: 20965832
[TBL] [Abstract][Full Text] [Related]
8. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
9. A notable accessory screening program for detection of cervical intraepithelial neoplasia.
Tsai HT; Tsai YM; Yang SF; Lee CH; Lin LY; Lee S; Wu MT
Pathol Biol (Paris); 2009 Sep; 57(6):477-82. PubMed ID: 18586410
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women.
Zhang R; Shi TY; Ren Y; Lu H; Wei ZH; Hou WJ; Zhang M; Xu C
J Clin Virol; 2013 Sep; 58(1):144-8. PubMed ID: 23849649
[TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
12. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
14. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
15. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
Zhao C; Li Z; Nayar R; Levi AW; Winkler BA; Moriarty AT; Barkan GA; Rao J; Miller F; Fan F; Zhou Z; Si Q; Fischer AH; Sturgis CD; Jing X; Marshall CB; Witt BL; Birdsong GG; Crothers BA
Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
17. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
18. ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients.
Husaiyin S; Jiao Z; Yimamu K; Maisaidi R; Han L; Niyazi M
PLoS One; 2021; 16(12):e0260915. PubMed ID: 34855928
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.
Liang H; Fu M; Zhou J; Song L
Oncol Lett; 2016 Aug; 12(2):887-892. PubMed ID: 27446364
[TBL] [Abstract][Full Text] [Related]
20. Study on the Significance of Folate Receptor-Mediated Staining Solution (FRD) Staining in Screening High Grade Cervical Lesions.
Xiao S; Xie H; Zhu X; Li X; Yi S; Deng X; Xue M
Med Sci Monit; 2019 Apr; 25():2792-2801. PubMed ID: 30990212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
